Caplacizumab Active Not Recruiting Phase 3 Trials for Acquired Thrombotic Thrombocytopenic Purpura Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02878603Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)